Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)

NCT05981118 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

40

Enrollment

OTHER

Sponsor class

Conditions

ICD10 Code L40.9 for Psoriasis

Interventions

DRUG: Betamethasone dipropionate 0.05%
DRUG: Tapinarof

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]